Seattle, WA -- (SBWIRE) -- 10/05/2017 -- The global medical plastics market is expected to reach USD 6,978.03 Million by 2020. This growth is fueled by the aging population increasing the demand for existing and new medical technologies and growing application sectors globally.

Download PDF http://www.marketsandmarkets.com/pdfdownload.asp?id=83738633

Polyvinyl Chloride – The largest medical plastics, by type

Polyvinyl chloride is the largest market in the medical plastics market. PVC is the third most widely produced synthetic plastic polymer, after polyethylene and polypropylene. The demand for PVC is more as PVC is compatible with different kinds of additives that make it a versatile polymer and thus suitable to be used in manufacturing of medical plastics. PVC is widely used in manufacturing of Class I medical devices. Medical devices that are manufactured using PVC can be easily sterilized using such methods as steam, radiation, or ethylene oxide. The two main applications for medically approved PVC compounds are flexible containers and tubing.

Disposable medical devices – The largest application market for medical plastics

Disposable medical devices can be disposed or can be thrown away once they are used. Medical devices such as contact lenses, hypodermic needles, disposable enemas, dialysis disposables, medical and cleaning gloves, and other medical products are considered in this segment. Among the major disposable medical devices, dialysis disposables witness the fastest growth rate globally, because of increasing end-stage kidney disorders and high frequency of therapeutic requirements. Polymers such as silicone hydrogel, polyethylene, polystyrene, epoxy resins, and polypropylene are used for manufacturing disposable medical devices.

The demand for disposable medical devices is more in the emerging economies as the health care sector in these economies has expanded and modernized. Abbott Laboratories (U.S.), Access Closure (U.S.), Advanced Medical Solutions Group plc (U.K.), Lohmann & Rauscher GmbH & Company KG (Germany), Medline Industries Incorporated (U.S.), and Medtronic Incorporated (Ireland) are some of the notable companies that are operating in the disposable medical devices market.

Europe – The largest market for medical plastics

The European Union has a positive outlook for the medical industry. The emerging technology in the region has allowed it to produce better quality medical devices. The demand for medical devices has been increasing owing to rising awareness for early diagnosis and treatment of countless diseases in European countries. The medical device manufacturers are attracted towards Europe, as it is easy to get fast approvals and the regulatory bodies are flexible. This acts as a great advantage for the manufacturers because this reduces the launch time of the device. Thus, Europe is witnessing a large number of acquisitions and expansions in the medical and healthcare industry.

Get Report Sample http://www.marketsandmarkets.com/requestsample.asp?id=83738633

The global medical plastics market is a fragmented market owing to the large number of buyers and limited availability of suppliers across the globe. Also, the increasing rivalry among the players to obtain majority of the patents for medical plastics-based applications has played a major role in intensifying the level of competition. Major players such as Phillips-Medisize Corporation (U.S.), Freudenberg Medical (U.S.), Nolato AB (Sweden), Roechling Engineering Plastics (Germany), West Pharmaceutical Services, Inc. (U.S.), Parker Hannifin Corporation (U.S.), MedPlast Inc. (U.S.), and GW Plastics (U.S.) have adopted various organic and inorganic developmental strategies. These strategies majorly include expansion, merger & acquisition, partnerships, and new product launch & product development to achieve growth in the medical plastics market. They mainly focus on providing high-quality and low-cost medical plastics.

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: sales@marketsandmarkets.com